ShroomSpy

ShroomSpy

Pan Cyan

Panaeolus Cyanescens

Common Names: Blue Meanies, Pan Cyan

About

Panaeolus cyanescens, commonly known as the Blue Meanie, is a potent mushroom species known for its psychedelic properties. While Panaeolus cyanescens is primarily recognized for its psychedelic effects, there is growing interest in its potential mental health benefits. Research on psilocybin-containing mushrooms, including Panaeolus cyanescens, suggests that they may have therapeutic potential for various mental health conditions, such as depression, anxiety, and post-traumatic stress disorder (PTSD). Psilocybin is believed to work by influencing serotonin receptors in the brain, leading to profound and transformative experiences that can facilitate emotional healing and personal growth. It's important to note that the therapeutic use of Panaeolus cyanescens or any psychedelic substance should always be conducted under the guidance of trained professionals in a controlled and supportive environment. Furthermore, legal and ethical considerations must be taken into account.

Physical Characteristics

Caps:

Conic to convex, expanding to broadly convex and eventually flat with age. Dark brown to light gray or whitish color.

Gills:

Adnate to adnexed or emarginate, close, broad; grayish to cinnamon brown.

Psychoactive Effects

Euphoric

Describing intense feelings of happiness or excitement

Perceptual

The change in the way things are perceived, including changes in time perception, spatial perception, and perception of one's own body.

Visuals

Blue Meanies are well known to induce heavy visuals that are often fractal and colorful in nature.

Helps With

Depression

Relieves symptoms of depression, improving mood and outlook

Anxiety

Helps to alleviate feelings of worry, fear, and unease

Addiction

Helps to overcome addiction and substance abuse

PTSD

Helps to alleviate symptoms of post-traumatic stress disorder

OCD

Helps to alleviate symptoms of obsessive-compulsive disorder

ADD ADHD

Helps to alleviate symptoms of attention deficit disorder and attention deficit hyperactivity disorder

Pain

Microdosing psilocybin has been shown to help with certain types of pain

Migraines

Research shows that psilocybin, the active compound in magic mushrooms, has potential therapeutic benefits for migraines. A small-scale study conducted by Yale School of Medicine found that a single dose of psilocybin reduced the likelihood of having a migraine attack in two weeks.

Potential Side Effects

Nausea

A feeling of discomfort in the stomach with an urge to vomit

Medicinal Chemistry

Look Alike Species

Panaeolus Foenisecii

Specie:

Panaeolus foenisecii

Edibility:

inedible

Differences:Panaeolus foenisecii is generally smaller and less substantial than Panaeolus Cyanescens. It also tends to have a more conical cap, and does not blue as readily when bruised.

Mushroom Ratings

0.0

Based on 0 Review

5

★

4

★

3

★

2

★

1

★

Share your thoughts

If you've consumed this mushroom, share your thoughts with our community

Related Mushrooms

Pan Cyan

TTBVI

Panaeolus Cyanescens

4

Euphoric
Perceptual
Visuals

References

  • The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin

    • Interest in psychedelic research in the West is surging, however, clinical trials have almost exclusively studied synthetic compounds such as MDMA, ketamine, DMT, LSD, ibogaine, and psilocybin. To date, few clinical trials have utilized whole mushroom/plant material like Psilocybe mushrooms, Iboga, or Ayahuasca. Individuals participating in the Roots To Thrive Psilocybin-Assisted Therapy for End of Life Distress program were administered synthetic psilocybin, whole Psilocybe cubensis, and mycological extract on separate occasions and post-treatment interview transcripts were qualitatively analyzed to discern themes and patterns. There was broad consensus that all three forms were helpful and similar, all generating visual and perceptual distortions, emotional and cognitive insight, and mystical experiences. However, synthetic psilocybin was said to feel less natural compared to organic forms, and the overall quality of experience of synthetic psilocybin was inferior to the organic forms. Research should be conducted with whole psychedelic mushrooms and extract in addition to synthetic psilocybin given this preliminary data, especially when considering that medicine keepers around the world have utilized whole mushrooms and plant material for millennia.

    2024

  • Mushroom, Psilocybin

    • Psilocybin and related compounds have been isolated from more than 150 species of mushroom but are primarily found in the following genera: Psilocybe, Panaeolus, Gymnopilus. The most commonly referenced literature are: Psilocybe cubensis, mexicana, cyanescens, semilanceata; Panaeolus foenisecii; Gymnopilus spectabilis; Psathyrella foenisecii.

    2024

  • An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus

    • This review discusses species identification, taxonomy and classification, available DNA sequence data and psychedelic species in Psilocybe, Panaeolus, Pluteus, and Gymnopilus, as well as similar looking genera that could be harmful.

    2023

  • Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes

    • This study examines the effects and safety of Panaeolus cyanescens extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes.

    2020

  • Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

    • Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer.

    2010